Relvar Ellipta is indicated for the symptomatic treatment of adults with COPD with a FEV1 <70% predicted normal (post-bronchodilator) in patients with an exacerbation history despite bronchodilator therapy. What is Relvar Ellipta and what is it used for?

Relvar Ellipta should be used every day and not only when you have breathing problems or other symptoms of COPD and asthma. It should not be used to relieve a sudden attack of breathlessness or wheezing. If you get this sort of attack you must use a quick-acting inhaler (such as salbutamol).

2022年3月30日 · Relvar Ellipta is indicated for the symptomatic treatment of adults with COPD with a FEV 1 <70% predicted normal (post-bronchodilator) with an exacerbation history despite regular bronchodilator therapy.

2022年6月11日 · Relvar Ellipta is an inhaler for handling asthma and chronic obstructive pulmonary illness.It has two active elements: fluticasone furoate and vilanterol.

What is Relvar Ellipta and what is it used for? Relvar Ellipta is an inhaler for treating asthma and chronic obstructive pulmonary disease (COPD). • whose symptoms are adequately controlled with both inhaled corticosteroids and a long-acting beta-2 agonist.

Relvar Ellipta should be used every day and not only when you have breathing problems or other symptoms of COPD and asthma. It should not be used to relieve a sudden attack of breathlessness or wheezing. If you get this sort of attack you must use a quick-acting inhaler (such as salbutamol).

White powder in a light grey inhaler (Ellipta) with a yellow mouthpiece cover and a dose counter. Each single inhalation provides a delivered dose (the dose leaving the mouthpiece) of 92 micrograms of fluticasone furoate and 22 micrograms of vilanterol (as trifenatate).

2023年5月26日 · Relvar inhaler is used to help control symptoms in asthma and chronic obstructive pulmonary disease (COPD). COPD is a disease affecting the lungs which make it harder for the person to breathe as the disease gets worse. Relvar contains two ingredients, Vilanterol and Fluticasone.

Relvar Ellipta contains two medicines, fluticasone furoate and vilanterol. Relvar Ellipta is a long-acting bronchodilator combined with an inhaled corticosteroid that is taken once daily for the treatment of asthma and COPD.

Fluticasone furoate with vilanterol (Relvar® Ellipta®) for symptomatic treatment of adults with chronic obstructive pulmonary disease with a forced expiratory volume in 1 second (FEV 1) less than 70% predicted normal (post-bronchodilator) with an exacerbation history despite regular bronchodilator therapy (April 2014)